Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites
- PMID: 14526103
- PMCID: PMC218752
- DOI: 10.1073/pnas.2032858100
Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites
Abstract
Apical membrane antigen 1 (AMA-1) is a promising vaccine candidate for Plasmodium falciparum malaria. Antibodies against AMA-1 of P. falciparum (PfAMA-1) interrupt merozoite invasion into RBCs. Initially localized within the apical complex, PfAMA-1 is proteolytically processed and redistributed circumferentially on merozoites at about the time of their release and invasion into RBCs. An 83-kDa precursor form of PfAMA-1 is processed to 66-kDa and then to 48- and 44-kDa products. We show that, even at low concentrations, IgG antibodies against correctly folded recombinant PfAMA-1 cross-linked and trapped the 52-, 48-, and 44-kDa proteolytic products on merozoites. These products are normally shed into the culture medium. At higher concentrations antibodies inhibited invasion into RBCs and caused a reduction in the amount of 44- and 48-kDa products, both on merozoites and in the culture medium. A corresponding increase also occurred in the amount of the 66- and 52-kDa forms detected on the merozoites. These antibodies also prevented circumferential redistribution of AMA-1. In contrast, monovalent invasion-inhibitory Fab fragments caused accumulation of 66- and 52-kDa forms, with no cross-linking, trapping, or prevention of redistribution. Antibodies at low concentrations can be used as trapping agents for intermediate and soluble forms of AMA-1 and are useful for studying proteolytic processing of AMA-1. With this technique, it was confirmed that protease inhibitor chymostatin and Ca2+ chelators can inhibit the breakdown of the 66-kDa form. We propose that antibodies to AMA-1 capable of inhibiting erythrocyte invasion act by disrupting proteolytic processing of AMA-1.
Figures








Similar articles
-
Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.Infect Immun. 2005 Apr;73(4):2116-22. doi: 10.1128/IAI.73.4.2116-2122.2005. Infect Immun. 2005. PMID: 15784553 Free PMC article.
-
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.Mol Biochem Parasitol. 1994 Sep;67(1):59-68. doi: 10.1016/0166-6851(94)90096-5. Mol Biochem Parasitol. 1994. PMID: 7838184
-
Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.Malar J. 2015 Feb 5;14:58. doi: 10.1186/s12936-015-0547-0. Malar J. 2015. PMID: 25652589 Free PMC article.
-
Antibodies and Plasmodium falciparum merozoites.Trends Parasitol. 2001 Apr;17(4):194-7. doi: 10.1016/s1471-4922(00)01946-2. Trends Parasitol. 2001. PMID: 11282510 Review.
-
Apical membrane antigen 1 as an anti-malarial drug target.Curr Top Med Chem. 2011;11(16):2039-47. doi: 10.2174/156802611796575885. Curr Top Med Chem. 2011. PMID: 21619512 Review.
Cited by
-
Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population.BMC Infect Dis. 2012 Feb 2;12:32. doi: 10.1186/1471-2334-12-32. BMC Infect Dis. 2012. PMID: 22299616 Free PMC article.
-
Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.Infect Immun. 2006 Jan;74(1):798-801. doi: 10.1128/IAI.74.1.798-801.2006. Infect Immun. 2006. PMID: 16369044 Free PMC article.
-
Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.J Clin Microbiol. 2006 May;44(5):1665-73. doi: 10.1128/JCM.44.5.1665-1673.2006. J Clin Microbiol. 2006. PMID: 16672391 Free PMC article.
-
Protein kinase PfPK2 mediated signalling is critical for host erythrocyte invasion by malaria parasite.PLoS Pathog. 2023 Nov 21;19(11):e1011770. doi: 10.1371/journal.ppat.1011770. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 37988347 Free PMC article.
-
Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays.Malar J. 2010 Jun 3;9:152. doi: 10.1186/1475-2875-9-152. Malar J. 2010. PMID: 20525251 Free PMC article.
References
-
- Dunn, B. M., ed. (1991) Proteases of Infectious Agents (Academic, New York).
-
- Blackman, M. J. (2000) Curr. Drug Targets 1, 59–83. - PubMed
-
- Holder, A. A., Guevara Patino, J. A., Uthaipibull, C., Syed, S. E., Ling, I. T., Scott-Finnigan, T. & Blackman, M. J. (1999) Parassitologia (Rome) 41, 409–414. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous